Application of ihMT MRI in Multiple Sclerosis
Recruiting
N/A
Interventional Study
Sclerosis, Multiple
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The development of in vivo biomarkers sensitive to myelin disruption represents a major clinical need to be able to monitor the demyelination processes as well as the effect of remyelinating therapies in multiple sclerosis. The investigators recently proposed a technique, derived from the conventional magnetisation transfer (MT): inhomogeneous Magnetisation Transfer (ihMT). In preliminary studies,…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* For Patients and Controls :
* Adult patient, male and female, age 18 to 45
* Patient affiliated with health insurance coverage,
* Patient who signed a free and informed consent after receiving detailed, understandable and honest information,
* For patients only :
* P…
Contacts